Insights

Strategic Market Expansion ImmunoChemistry Technologies has recently integrated Biosensis Pty Ltd, enhancing its product portfolio and market reach in the life science reagent market. This expansion presents opportunities to upsell new assay kits and reagents to existing clients and target new customer segments looking for comprehensive immunoassay solutions.

Innovative Product Launches The company has launched new conjugation kits and recombinant chimeric antibodies, signaling ongoing innovation in assay development and molecular diagnostics. These product extensions can be leveraged as sales touchpoints for clients seeking cutting-edge tools for biomarker detection and antibody conjugation.

Robust R&D Focus With a strong emphasis on assay development and protein chemistry expertise, ImmunoChemistry Technologies offers customized assay services and scale-up manufacturing. This focus provides a sales opportunity by offering tailored solutions to biotech and pharma companies seeking reliable assay development and production support.

Moderate Revenue Growth While the company operates with a modest revenue range between $1 million and $10 million, its strategic partnerships, recent product launches, and market expansions indicate potential for growth. This presents opportunities to target emerging biotech startups and research institutions needing cost-effective, high-quality assay and reagent products.

Market-Driven Product Development Recent investments in new assay kits and recombinant antibodies reflect a responsiveness to current market trends in diagnostics and research. This positioning allows sales teams to align pitches with clients demanding innovative, validated solutions for cell viability, immunoassays, and molecular diagnostics, fostering long-term customer relationships.

ImmunoChemistry Technologies, LLC Tech Stack

ImmunoChemistry Technologies, LLC uses 8 technology products and services including jsDelivr, Shopify, Font Awesome, and more. Explore ImmunoChemistry Technologies, LLC's tech stack below.

  • jsDelivr
    Content Delivery Network
  • Shopify
    E-commerce
  • Font Awesome
    Font Scripts
  • Polyfill
    Javascript Libraries
  • Shopify Product Reviews
    Online Review Management
  • Priority Hints
    Performance
  • reCAPTCHA
    Security
  • X-XSS-Protection
    Security

Media & News

ImmunoChemistry Technologies, LLC's Email Address Formats

ImmunoChemistry Technologies, LLC uses at least 2 format(s):
ImmunoChemistry Technologies, LLC Email FormatsExamplePercentage
First.Last@immunochemistry.comJohn.Doe@immunochemistry.com
57%
First@immunochemistry.comJohn@immunochemistry.com
43%
FLast@antibodiesinc.comJDoe@antibodiesinc.com
86%
Last@antibodiesinc.comDoe@antibodiesinc.com
11%
FirstL@antibodiesinc.comJohnD@antibodiesinc.com
3%

Frequently Asked Questions

Where is ImmunoChemistry Technologies, LLC's headquarters located?

Minus sign iconPlus sign icon
ImmunoChemistry Technologies, LLC's main headquarters is located at P/o Box 1560 Davis, California 95617 United States. The company has employees across 1 continents, including North America.

What is ImmunoChemistry Technologies, LLC's phone number?

Minus sign iconPlus sign icon
You can contact ImmunoChemistry Technologies, LLC's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is ImmunoChemistry Technologies, LLC's official website and social media links?

Minus sign iconPlus sign icon
ImmunoChemistry Technologies, LLC's official website is antibodiesinc.com and has social profiles on LinkedIn.

How much revenue does ImmunoChemistry Technologies, LLC generate?

Minus sign iconPlus sign icon
As of March 2026, ImmunoChemistry Technologies, LLC's annual revenue is estimated to be $3.8M.

What is ImmunoChemistry Technologies, LLC's SIC code NAICS code?

Minus sign iconPlus sign icon
ImmunoChemistry Technologies, LLC's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does ImmunoChemistry Technologies, LLC have currently?

Minus sign iconPlus sign icon
As of March 2026, ImmunoChemistry Technologies, LLC has approximately 4 employees across 1 continents, including North America. Key team members include Vice President Of Bd & Marketing, Advisory Board Member: K. P.President & Chief Manager: S. H.Vice President, Marketing And Operations: H. S.. Explore ImmunoChemistry Technologies, LLC's employee directory with LeadIQ.

What industry does ImmunoChemistry Technologies, LLC belong to?

Minus sign iconPlus sign icon
ImmunoChemistry Technologies, LLC operates in the Biotechnology Research industry.

What technology does ImmunoChemistry Technologies, LLC use?

Minus sign iconPlus sign icon
ImmunoChemistry Technologies, LLC's tech stack includes jsDelivrShopifyFont AwesomePolyfillShopify Product ReviewsPriority HintsreCAPTCHAX-XSS-Protection.

What is ImmunoChemistry Technologies, LLC's email format?

Minus sign iconPlus sign icon
ImmunoChemistry Technologies, LLC's email format typically follows the pattern of First.Last@immunochemistry.com. Find more ImmunoChemistry Technologies, LLC email formats with LeadIQ.

When was ImmunoChemistry Technologies, LLC founded?

Minus sign iconPlus sign icon
ImmunoChemistry Technologies, LLC was founded in 1994.

ImmunoChemistry Technologies, LLC

Biotechnology ResearchCalifornia, United States2-10 Employees

ImmunoChemistry Technologies, LLC (ICT) is a privately held biotechnology company based in Davis, California, USA.  ICT is your partner in cell viability assays, immunoassays, and assay services. With decades of assay and protein chemistry expertise, ICT has a wide range of products for immunoassay, cellular, and molecular diagnostics development. 

ICT’s coating buffers, blockers, sample and assay diluents, conjugate stabilizers, and wash buffer all work together to minimize the build up of unwanted proteins to generate a very clean signal.  These products work together to address common issues during ELISA and assay development, such as specificity, sensitivity, reproducibility, and shelf-life.   

ICT’s viability assays include a large range of fluorescent whole cell assays for intracellular apoptosis detection and cellular analysis. ICT’s line of assay kits can detect apoptosis, necrosis, intracellular caspase activity, cell-mediated cytotoxicity, activated serine proteases, oxidative stress, mitochondrial membrane permeability, and much more!

ICT’s service laboratory specializes in a wide variety of immunoassay and assay-related services.  Our assay development scientists have years of experience with protein chemistry and assay optimization.  We can also scale up and manufacture an assay for internal use for clients.  

Our wide range of products includes coating buffers, blockers, sample and assay diluents, protein stabilizers, and substrates for immunoassay and molecular diagnostics applications.  Our cell viability assays include a large range of fluorescent whole cell assays for intracellular apoptosis detection and cellular analysis, our assay kits can detect apoptosis, necrosis, intracellular caspase activity, cell-mediated cytotoxicity, activated serine proteases, oxidative stress, mitochondrial membrane permeability, and many more applications!

Section iconCompany Overview

Headquarters
P/o Box 1560 Davis, California 95617 United States
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1994
Employees
2-10

Section iconFunding & Financials

  • $1M$10M

    ImmunoChemistry Technologies, LLC's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    ImmunoChemistry Technologies, LLC's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.